Sitagliptin Phosphate Hydrate Tablets 100mg (Januvia® / ジャヌビア錠100mg)

JPY ¥17,000

Japanese Selective DPP-4 Inhibitor antidiabetic agent (Sitagliptin Phosphate Hydrate 100mg). Oral tablet for treatment of type 2 diabetes mellitus. 100 tablets [10 tablets (PTP) x 10]. Mfd. by MSD K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥15,640
10 - 19 12% JPY ¥14,960
20 + 18% JPY ¥13,940
SKU: JAN-100-TAB Category:

Description

Product Overview / 商品概要

Januvia Tablets 100mg (ジャヌビア錠100mg)
Generic: Sitagliptin Phosphate Hydrate / シタグリプチンリン酸塩水和物
Therapeutic Category: Selective DPP-4 Inhibitor, Antidiabetic Agent / 選択的DPP-4阻害剤、糖尿病用剤
Manufactured by: MSD K.K. / MSD株式会社

Composition & Specification / 組成・規格

Active Ingredient: Sitagliptin 100mg per tablet / シタグリプチンとして100mg
Additives: Microcrystalline cellulose, Anhydrous dibasic calcium phosphate, Croscarmellose sodium, Magnesium stearate, Sodium stearyl fumarate, Propyl gallate, Polyvinyl alcohol (partially saponified), Titanium oxide, Macrogol 4000, Talc, Yellow ferric oxide, Ferric oxide / 結晶セルロース、無水リン酸水素カルシウム、クロスカルメロースナトリウム、ステアリン酸マグネシウム、フマル酸ステアリルナトリウム、没食子酸プロピル、ポリビニルアルコール(部分けん化物)、酸化チタン、マクロゴール4000、タルク、黄色三二酸化鉄、三二酸化鉄
Appearance: Round, film-coated tablet, light yellowish-red, diameter: 9.8mm, thickness: 4.2mm, weight: approx. 416mg, identification code: MSD 277
外観: 円形、フィルムコーティング錠、うすい赤黄色、直径:9.8mm、厚さ:4.2mm、重量:約416mg、識別コード:MSD 277

Indications / 効能効果

EN: Type 2 diabetes mellitus
JA: 2型糖尿病

Dosage and Administration / 用法用量

EN: The usual adult oral dose is 50mg of sitagliptin once daily. If the response is insufficient, the dose may be increased to 100mg once daily with careful monitoring.
JA: 通常、成人にはシタグリプチンとして50mgを1日1回経口投与する。なお、効果不十分な場合には、経過を十分に観察しながら100mg 1日1回まで増量することができる。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; patients with severe ketosis, diabetic coma or pre-coma, or type 1 diabetes; patients with severe infection, perioperative status, or serious trauma
JA: 本剤の成分に対し過敏症の既往歴のある患者、重症ケトーシス・糖尿病性昏睡又は前昏睡・1型糖尿病の患者、重症感染症・手術前後・重篤な外傷のある患者

Regulatory Information / 規制情報

Approval No.: 22100AMX02259000
Sales Started: December 2009 / 2009年12月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 2 years / 2年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Sitagliptin Phosphate Hydrate Tablets 100mg (Januvia® / ジャヌビア錠100mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Sitagliptin Phosphate Hydrate Tablets 100mg (Januvia®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.